stockrowOscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
- Revenue
- +72.1%
- EPS
- +201.9%
- Free cash flow
- −24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow OSCR
Alert me
Oscar Health, Inc. (OSCR) Revenue
Oscar Health, Inc.'s revenue for fiscal 2025 was $11.7B, up 27.5% from $9.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $17.5B. Over the past ten years it has ranged from $462.8M (fiscal 2020) to $11.7B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Oscar Health, Inc. ranks 8th of 12 Healthcare Plans companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $11.7B | 27.50% |
| FY2024 | $9.2B | 56.54% |
| FY2023 | $5.9B | 47.92% |
| FY2022 | $4.0B | 115.57% |
| FY2021 | $1.8B | 297.30% |
| FY2020 | $462.8M | (5.20%) |
| FY2019 | $488.2M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $5.1B | 5.31% |
| Jun 2026 | $4.9B | 5.01% |
| Mar 2026 | $4.6B | 65.66% |
| Dec 2025 | $2.8B | (6.05%) |
| 23 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CI Cigna Group compare | $286.3B |
| CNC Centene Corporation compare | $203.9B |
| ELV Elevance Health, Inc. compare | $201.8B |
| HUM Humana Inc. compare | $154.2B |
| MOH Molina Healthcare, Inc compare | $44.1B |
| OSCR Oscar Health, Inc. | $17.5B |
| ALHC Alignment Healthcare, Inc. compare | $4.9B |
| CLOV Clover Health Investments, Corp. compare | $2.7B |
| PGNY Progyny, Inc. compare | $1.3B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on OSCR
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement